OCUGEN INC (OCGN) — insider trading
Health Care · NASDAQ
OCUGEN INC (OCGN) has 19 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 2 open-market sales among the most recent 19 (latest 2026-09-09).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-09 | Musunuri Shankar | Director, Officer (Chief Executive Officer) | Open-market sale | 57,264 | $1.12 | $64.1K | Form 4 |
| 2026-09-09 | Musunuri Shankar | Director, Officer (Chief Executive Officer) | Open-market sale | 468,727 | $1.12 | $525.0K | Form 4 |
| 2026-06-15 | Johnson-Greene Treerita Essalima | Officer (Chief Financial Officer) | Open-market purchase | 21,000 | $1.23 | $25.8K | Form 4 |
| 2026-06-11 | Coleman Blaise | Director | Grant / award / vesting (derivative) | 170,100 | — | $0 | Form 4 |
| 2026-06-11 | Zhang Junge | Director | Grant / award / vesting (derivative) | 170,100 | — | $0 | Form 4 |
| 2026-06-11 | Castillo Kirsten | Director | Grant / award / vesting (derivative) | 170,100 | — | $0 | Form 4 |
| 2026-06-11 | Chandrasekhar Satishchandran | Director | Grant / award / vesting (derivative) | 170,100 | — | $0 | Form 4 |
| 2026-06-11 | Kompella Uday | Director | Grant / award / vesting (derivative) | 170,100 | — | $0 | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion (derivative) | 66,929 | — | $0 | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion (derivative) | 112,205 | — | $0 | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion | 66,929 | $1.42 | $95.0K | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion | 112,205 | $0.46 | $51.6K | Form 4 |
| 2026-04-01 | Zhang Junge | Director | Option exercise / conversion | 15,000 | $0.51 | $7.7K | Form 4 |
| 2026-01-02 | Ramachandran Ramesh | Officer (Chief Accounting Officer) | Grant / award / vesting (derivative) | 310,950 | — | $0 | Form 4 |
| 2026-01-02 | Ramachandran Ramesh | Officer (Chief Accounting Officer) | Grant / award / vesting | 207,300 | — | $0 | Form 4 |
| 2026-01-02 | Musunuri Shankar | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 3,123,201 | — | $0 | Form 4 |
| 2026-01-02 | Musunuri Shankar | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 3,123,201 | — | $0 | Form 4 |
| 2025-06-05 | Chandrasekhar Satishchandran | Director | Grant / award / vesting (derivative) | 151,316 | — | $0 | Form 4 |
Ask the chat about OCGN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: OCUGEN INC (OCGN).
Last updated 2026-09-09 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.